SCHEMBL3971131

SCHEMBL3971131

Brc1cccc(C2=CCC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
ALDH1A1 P00352 5/20 0.41
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
TP53 P04637 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
IDO1 P14902 1/20 0.39
METAP2 P50579 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPK1 P28482 1/20 0.38
MAPT P10636 1/20 0.38
HK1 P19367 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1055485 0.96 CHRNB4 (0.43) CHRNB4CHRNA3ALDH1A1RAB9ANPC1
SCHEMBL13832933 0.87 CHRNB4 (0.40) CHRNB4CHRNA3ALDH1A1RAB9ANPC1
SCHEMBL968176 0.86 CHRNB4 (0.46) CHRNB4CHRNA3ALDH1A1RAB9ANPC1
SCHEMBL971143 0.84 CHRNB4 (0.49) CHRNB4CHRNA3ALDH1A1RAB9ANPC1
SCHEMBL19027906 0.84 CHRNB4 (0.38) CHRNB4CHRNA3ALDH1A1RAB9ANPC1
SCHEMBL15823144 0.83 CHRNB4 (0.47) CHRNB4CHRNA3ALDH1A1SMN1; SMN2HPGD
SCHEMBL18562454 0.79 CHRNB4 (0.40) CHRNB4CHRNA3ALDH1A1RAB9ANPC1
SCHEMBL932928 0.77 PIK3CD (0.45) CHRNB4CHRNA3ALDH1A1RAB9ANPC1
SCHEMBL904011 0.77 HTR2C (0.66)
SCHEMBL29546450 0.75 ALDH1A1 (0.52) CHRNB4CHRNA3ALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036805-A Compound containing phosphaphenanthrene bonded benzocyclobutene, and preparation method and application thereof 武汉迪赛环保新材料股份有限公司 2026-05-15 CN disclosed
CN-118271184-A Dendritic structural compound, compound thereof and organic electroluminescent device 中国科学院长春应用化学研究所 2024-07-02 CN disclosed
CN-115417773-B Dendritic structural compound, compound thereof and organic electroluminescent device 中国科学院长春应用化学研究所 2024-05-28 CN disclosed
CN-115417773-A Dendritic structure compound and compound thereof, and organic electroluminescent device 中国科学院长春应用化学研究所 2022-12-02 CN disclosed
US-20220199906-A1 POLYMER FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2022-06-23 US disclosed
CN-106543002-B Aryl cyclobutene 陶氏环球技术有限责任公司 2022-06-17 CN disclosed
EP-3950767-A1 POLYMER FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL Chemical & Material Co., Ltd. (JP) 2022-02-09 EP disclosed
CN-113631626-A Polymer for organic electroluminescent element and organic electroluminescent element 日铁化学材料株式会社 2021-11-09 CN disclosed
WO-2020203203-A1 POLYMER FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT 日鉄ケミカル&マテリアル株式会社 2020-10-08 WO disclosed
US-10030165-B2 Arylcyclobutenes DOW GLOBAL TECHNOLOGIES LLC (US) 2018-07-24 US disclosed
US-5422410-A Heating the polymerized vinylbenzocyclobutene with styrene monomer, decyclizing the cyclobutene side ring to form chain extension and crosslinking THE DOW CHEMICAL COMPANY (US) 1995-06-06 US disclosed
US-5391650-A Amorphous, low viscosity and self-curing; workability; molding materials; composites; adhesives; binders; coatings; heat resistance THE DOW CHEMICAL COMPANY (US) 1995-02-21 US disclosed
WO-1994025903-A1 PARTIALLY POLYMERIZED RESINS THE DOW CHEMICAL COMPANY (US) 1994-11-10 WO disclosed
US-5120884-A Preparation of hydroxy arylcyclobutenes THE DOW CHEMICAL COMPANY (US) 1992-06-09 US disclosed
US-5002808-A Adhesion methods employing benzocyclobutene-based organosilane adhesion aids THE DOW CHEMICAL COMPANY (US) 1991-03-26 US disclosed
US-4898999-A Process for halogenating cyclobutenoarenes SHELL OIL COMPANY (US) 1990-02-06 US disclosed
EP-0346959-A1 Process for halogenating cyclobutenoarenes SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1989-12-20 EP disclosed
WO-1989009658-A1 BENZOCYCLOBUTENE-BASED ORGANOSILANE ADHESION AIDS THE DOW CHEMICAL COMPANY (US) 1989-10-19 WO disclosed
EP-0334269-A2 Benzocyclobutene-based organosilane adhesion aids THE DOW CHEMICAL COMPANY (US) 1989-09-27 EP disclosed
US-4831172-A Benzocyclobutene-based organosilane adhesion aids THE DOW CHEMICAL COMPANY (US) 1989-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10030165-B2 Arylcyclobutenes NOD2, GNE, BMI1 CHRNB4 470/4885CHRNA3 1054/4885ALDH1A1 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.